|

5-Azacitidine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Oral 5-Azacitidine, Vidaza

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Virginia1

Indications

  • Lymphoma, T-Cell1
  • Cancer1

Charlottesville, Virginia1 trial

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

University of Virginia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.